These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7484819)

  • 1. What's in the pipeline?
    Manuel SM
    Am Pharm; 1995 Sep; NS35(9):8-9. PubMed ID: 7484819
    [No Abstract]   [Full Text] [Related]  

  • 2. Photoprotection by topical DNA repair enzymes: molecular correlates of clinical studies.
    Yarosh DB; O'Connor A; Alas L; Potten C; Wolf P
    Photochem Photobiol; 1999 Feb; 69(2):136-40. PubMed ID: 10048308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme therapy of xeroderma pigmentosum: safety and efficacy testing of T4N5 liposome lotion containing a prokaryotic DNA repair enzyme.
    Yarosh D; Klein J; Kibitel J; Alas L; O'Connor A; Cummings B; Grob D; Gerstein D; Gilchrest BA; Ichihashi M; Ogoshi M; Ueda M; Fernandez V; Chadwick C; Potten CS; Proby CM; Young AR; Hawk JL
    Photodermatol Photoimmunol Photomed; 1996 Jun; 12(3):122-30. PubMed ID: 8956362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human bone morphogenetic proteins in the treatment of fractures.
    Kain MS; Einhorn TA
    Foot Ankle Clin; 2005 Dec; 10(4):639-50, viii. PubMed ID: 16297824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group.
    Yarosh D; Klein J; O'Connor A; Hawk J; Rafal E; Wolf P
    Lancet; 2001 Mar; 357(9260):926-9. PubMed ID: 11289350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical enzyme therapy for skin diseases?
    Kraemer KH; DiGiovanna JJ
    J Am Acad Dermatol; 2002 Mar; 46(3):463-6. PubMed ID: 11862191
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone morphogenetic proteins and the induction of bone formation: from laboratory to patients.
    Ripamonti U; Heliotis M; Ferretti C
    Oral Maxillofac Surg Clin North Am; 2007 Nov; 19(4):575-89, vii. PubMed ID: 18088907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained release carriers used to delivery bone morphogenetic proteins in the bone healing process.
    Issa JP; Bentley MV; Iyomasa MM; Sebald W; De Albuquerque RF
    Anat Histol Embryol; 2008 Jun; 37(3):181-7. PubMed ID: 18070240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periodontal tissue regeneration by recombinant human transforming growth factor-beta 3 in Papio ursinus.
    Teare JA; Ramoshebi LN; Ripamonti U
    J Periodontal Res; 2008 Feb; 43(1):1-8. PubMed ID: 18230100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OP-1 clinical studies.
    Friedlaender GE
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S160-1. PubMed ID: 11314795
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone morphogenetic proteins in clinical applications.
    Gautschi OP; Frey SP; Zellweger R
    ANZ J Surg; 2007 Aug; 77(8):626-31. PubMed ID: 17635273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. rhBMP-2 as an option for reconstructing mandibular continuity defects.
    Herford AS
    J Oral Maxillofac Surg; 2009 Dec; 67(12):2679-84. PubMed ID: 19925991
    [No Abstract]   [Full Text] [Related]  

  • 13. [Application of BMP to bone repair].
    Yamaguchi A
    Clin Calcium; 2007 Feb; 17(2):263-9. PubMed ID: 17272885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic proteins and osseointegration: current knowledge - future possibilities.
    Huang YH; Polimeni G; Qahash M; Wikesjö UM
    Periodontol 2000; 2008; 47():206-23. PubMed ID: 18412583
    [No Abstract]   [Full Text] [Related]  

  • 15. [Is it possible to promote fracture repair? Review of biological methods to accelerate fracture repair].
    Goldwirth M; Krasin E
    Harefuah; 1999 Jun; 136(11):893-6. PubMed ID: 10955140
    [No Abstract]   [Full Text] [Related]  

  • 16. [An experimental study on the bone repairing ability of recombinant human bone morphogenetic protein-2-coral composited artificial bone].
    Zhang S; Mao T; Wang H
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1998 Jan; 33(1):13-4. PubMed ID: 11774667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poisson distribution to assess actinic keratoses in xeroderma pigmentosum.
    Lachenbruch P; Marzella L; Schwieterman W; Weiss K; Siegel J
    Lancet; 2001 Sep; 358(9285):925. PubMed ID: 11575371
    [No Abstract]   [Full Text] [Related]  

  • 18. Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2.
    Chen B; Lin H; Wang J; Zhao Y; Wang B; Zhao W; Sun W; Dai J
    Biomaterials; 2007 Feb; 28(6):1027-35. PubMed ID: 17095085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein-2: biology and applications.
    Riley EH; Lane JM; Urist MR; Lyons KM; Lieberman JR
    Clin Orthop Relat Res; 1996 Mar; (324):39-46. PubMed ID: 8595775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human bone morphogenetic protein 2 enhances bone healing in an experimental model of fractures at risk of non-union.
    Eckardt H; Christensen KS; Lind M; Hansen ES; Hall DW; Hvid I
    Injury; 2005 Apr; 36(4):489-94. PubMed ID: 15755429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.